There was no difference in stiffness between KH and STS hearts at the commencement of ischaemia (p = 0.23) or the end (p = 0.74).
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There was no difference in stiffness between KH and STS hearts at the commencement of ischaemia (p = 0.23) or the end (p = 0.74).
There was no stiffness difference in hearts that did recover compared with those that did not, at the beginning (p = 0.877) or end of ischaemia (p = 0.168).
Conclusion: SWE demonstrates changes in stiffness over time in warm ischaemic hearts. This may be of use in assessing hearts donated after circulatory death. SWE could not discriminate on the basis of stiffness between preservation solution or functional recovery for cold ischaemic hearts. The Canberra Hospital, Canberra, Australia Introduction: In-hospital mortality (IHM) for cardiac arrest patients remains a challenge in our institution with a large catchment. Primary coronary intervention (PCI) continues to have poorer outcomes when patients present following cardiac arrest, in cardiogenic shock (CS) or receive cardiopulmonary resuscitation (CPR).
Method: We analysed all activations of the cardiac catheterisation laboratory in 2018. We assessed rates of IHM and 30 day MACE following PCI in relation to the following variables: in-hospital (IHCA) or out-of-hospital cardiac arrest (OHCA), shockable or non-shockable rhythms, intubation and cardiogenic shock. IHCA were classified as outside Canberra vs referral from peripheral hospitals.
Results: 203 consecutive activations were analysed. 76% were male with mean age 60.7 years. Females had a mean age of 69.4 years (p < 0.0001). 110 (54%) activations occurred afterhours. 170 met STEMI criteria; 30 OHCA, 18 IHCA and 12 in CS. 9 patients (4.4%) required intubation prior to PCI. 36 (17.7%) had a shockable rhythm and 33 (16.3%) received CPR. The mortality rates of OHCA compared to IHCA were 26.7% vs 44.4%, respectively (OR 0.45, 95% CI 0.13 to 1.56, p = 0.21). IHM rates were highest in patients receiving inotropes or intubation (42.9% and 39.1%). Mortality rates for females were higher their male counterparts (15.0% vs 7.7%, OR 2.03, 95% CI 0.75 to 5.50, p = 0.16). Excluding IHM, only 7 patients (3.4%) had MACE at 30 days.
Conclusion: Our institution's IHM rates in OHCA are higher than IHCA likely from referral hospital delays to PCI from inter-hospital transfers. 
